Form 4 for IDXX Idexx Laboratories
Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0001567619-22-004788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-16 | 2022-02-14 | IDXX | TWIGGE GIOVANI | SVP | M - OptEx | $0.00 | +835 | 17.9K | +5% | $0 |
| D | 2022-02-16 | 2022-02-14 | IDXX | TWIGGE GIOVANI | SVP | F - Tax | $505.53 | -252 | 17.7K | -1% | -$127.4K |
| DM | 2022-02-16 | 2022-02-14 | IDXX | TWIGGE GIOVANI | SVP | M - OptEx | — | -835 | 1,586 | -34% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-14 | M | A | 115 | $0.00 | 17,982.48 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-14 | F | D | 252 | $505.53 | 17,730.48 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-14 | M | A | 211 | $0.00 | 17,358.48 | D | — | — | (F1) Includes a total of 19 shares purchased under the Issuer's Employee Stock Purchase Plan on September 30, 2021 and December 31, 2021. |
| 4 | Common | Common Stock | 2022-02-14 | M | A | 168 | $0.00 | 17,526.48 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-14 | M | A | 157 | $0.00 | 17,683.48 | D | — | — | |
| 6 | Common | Common Stock | 2022-02-14 | M | A | 184 | $0.00 | 17,867.48 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 211 | — | 1,754 | D | — · — to — | 211 Common Stock | (F7) Not applicable. (F2) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2018. |
| 8 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 115 | — | 1,130 | D | — · — to — | 115 Common Stock | (F7) Not applicable. (F6) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| 9 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 184 | — | 1,245 | D | — · — to — | 184 Common Stock | (F7) Not applicable. (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. |
| 10 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 157 | — | 1,429 | D | — · — to — | 157 Common Stock | (F7) Not applicable. (F4) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. |
| 11 | Derivative | Restricted Stock Unit | 2022-02-14 | M | D | 168 | — | 1,586 | D | — · — to — | 168 Common Stock | (F7) Not applicable. (F3) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. |